Prehabilitation for Lung Cancer Surgery (ROAR-LCS Trial)

This study, called the ROAR-LCS Trial, is looking at two different programs to help adults having lung cancer surgery. These programs, one called ROAR-LCS and another called BeFitMe, involve physical therapy and relaxation exercises before and after surgery. The goal is to see if these programs can help you recover better and have good results from your surgery. You can join if you are at least 18 years old, have non-small cell lung cancer that can be removed by surgery, and plan to have surgery at Ohio State University Comprehensive Cancer Center. The main goal of the study is to see how many people stick with the programs (adherence) and how many stay in the study (retention). This study is currently unclear on its recruitment status.

Study design
This interventional study plans to enroll 30 participants. Participants choose which of the two intervention arms they would like to participate in.
What's involved
You would provide blood samples and complete exercises at home using a portable exercise peddler and resistance bands. You would also access the BeFitMe application or attend in-person and virtual physical therapy sessions.
Compensation
Not stated in the trial record.
Follow-up
Your adherence will be measured at a 12-week follow-up session, and retention will be measured for up to 6 months after you join the study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07584239

Prehabilitation Physical Therapy and Relaxation Intervention Program to Promote Resiliency and Operative Success Among Adults Receiving Lung Cancer Surgery, ROAR-LCS Trial

Recruiting
NAAges 18+InterventionalSupportive care
Ohio State University Comprehensive Cancer Center
~30 participants
Updated 2026-05-26 on ClinicalTrials.gov
What's tested:Biospecimen CollectionExercise InterventionInternet-Based InterventionPhysical TherapyRelaxation TechniqueSurvey Administration

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Adherence (feasibility)
Measured over At 12 week follow up session
+1 more outcome measured
Resectable Lung Non-Small Cell Carcinoma
1 sites across 1 states
Ohio1
  • Carolyn J Presley, MD · PRINCIPAL_INVESTIGATOR · Ohio State University Comprehensive Cancer Center
The Ohio State University Comprehensive Cancer Center
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age ≥ 18 years
Diagnosed with: potentially resectable non small cell lung cancer (NSCLC) stage (9th edition: IB-IIIB)
Intent to receive surgery following neoadjuvant systemic therapy from the Ohio State University Comprehensive Cancer Center (OSUCCC) Thoracic Oncology Clinic
Patients who are at least 6 weeks out of the surgery date are eligible to participate
Willingness to participate and adhere to the study intervention program
Ability to understand and willingness to sign an informed consent document

Exclusion

Prisoners are excluded from participation
Patients already enrolled on a therapeutic clinical trial will be excluded from this study as to not confound any exploratory outcomes associated with this trial and/or any clinical trials evaluating novel anti-cancer therapies unless granted permission by the local site principal investigator (PI)
  • Adherence (feasibility)At 12 week follow up session

    Defined as completion of ≥ 8 of the program sessions (Resiliency and Operative Success among Adults Receiving Lung Cancer Surgery \[ROAR-LCS\]) and 3 out of the 5 repeated assessments (BeFitMe) at the end of the study period, whichever occurs first.

  • Retention (feasibility)Up to 6 months post recruitment

    Defined as the percentage of participants not lost to follow-up at 12 weeks (pre-operative), post-operative (around 12 weeks), and 6 months post recruitment.